Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover

Hepatology

Volumn 28, Issue 1, 1998, Pages 245-252

  Zeuzem, Stefan ^a,c   Schmidt, Jürgen M ^a   Lee, Jung Hun ^a   Von Wagner, Michael ^a,b   Teuber, Gerlinde ^a   Kurt Roth, W ^b  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; BILIRUBIN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; VIRUS RNA;

ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HALF LIFE TIME; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS REPLICATION;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; COHORT STUDIES; DRUG COMBINATIONS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RECOMBINANT PROTEINS; RIBAVIRIN; VIRUS REPLICATION;

EID: 0031807791     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280132     Document Type: Article

References (6)

1. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, et al. Immunohistochemical detection of fas antigen in liver tissue of patients with chronic hepatitis C. HEPATOLOGY 1994:19:1354-1359.
2. Fausto N, Webber EM. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology, 3rd ed. New York: Raven, 1994.
3. Gutterman JU. Cytokine therapeutics: lessons from interferon a. Proc Natl Acad Sci U S A 1994;91:1198-1205.
4. Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden AJ. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa. HEPATOLOGY 1997;26:226-231.
5. Herz AVM, Bonhoeffer S, Anderson RM, May RM, Nowak MA. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. Proc Natl Acad Sci U.S.A 1996;93:7247-7251.
6. Ning Q, Brown D, Parodo J, Cattral M, Fung L, Liu M, Rotstein O, Levy G. Ribavirin inhibits viral induced macrophage production of tumor necrosis factor, interleukin 1 and procoagulant activity and preserves Th1 cytokine production, but inhibits Th2 cytokine response [Abstract]. HEPATOLOGY 1996;24:355A.